Neutrogena Defending Class Action After Findings Of Benzene In SPF Products

J&J unit faces allegations of having exposed Neutrogena sunscreen consumers to avoidably high levels of carcinogenic benzene in a case seeking class action status in California federal court.

Johnson & Johnson’s Neutrogena Corporation had the highest levels of benzene detected in sunscreen products tested by Valisure LLC, says a consumer class-action complaint filed on 21 June in California’s Central District.

According to plaintiff and Florida resident Shelli French, who purchased Neutrogena Beach Defense Oil Free Body Sunscreen Spray SPF 100 from a local Walmart roughly once every three months for five years,

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America

Washington State TFCA Violators Likely To Face Conversation Before Penalties – DOE

 

The Washington State Department of Ecology will try to work with companies that violate the Toxic Free Cosmetics Act, rather than reflexively imposing the $5,000-per-violation fine for first-time offenders, says the law’s implementation planner. She noted financial assistance is available for small businesses, as well as incentives for companies adopting measures “beyond compliance.”

Adcomm Reform: Getting Needed Information More Important Than Vote Or Discussion

 

US FDA Office of New Drugs Director Peter Stein says review divisions have made the case that a discussion-only meeting would solicit the necessary input.

US FDA’s Petition Procedures No Place For OTC Acetaminophen Pediatric Dosing Enforcement

 

Requests for “enforcement actions are not within the scope of FDA’s citizen petition procedures,” CDER says, rejecting petition dosing device firm Parenteral Technologies submitted as it prepares for workshop on Pediatric Research Equity Act requirements for OTC NDA sponsors.